Company intelligence / Profile preview
IGXBio
Fairway, Kansas, United Statesigxbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
GenePro® has demonstrated production of CD8+ memory cells in non-human primates similar to those produced by Elite Controllers of HIV (individuals who control HIV progression without therapeutic drugs). The therapy is designed to promote anti-HIV immune response and facilitate virus control in HIV-infected subjects.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DNA vaccine
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Cannabis Science, Inc. (collaborative drug development deal announced May 2015 to combine GenePro® with CS-TATI-1, a cannabinoid-based therapeutic, to explore synergistic anti-inflammatory and anti-HIV effects)
Beyond the preview
Go deeper on IGXBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IGXBio.